Links from MedGen
Items: 7
| Gene(s) | Protein change | Condition(s) | Clinical significance (Last reviewed) | Review status |
---|
| - GRCh37:
- ChrX:135290774
- GRCh38:
- ChrX:136208615
| FHL1 | C221Y, C237Y, C250Y | Asymmetric septal hypertrophy | Likely pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr7:128492808
- GRCh38:
- Chr7:128852754
| FLNC, FLNC-AS1 | | Hypertrophic cardiomyopathy 26, Asymmetric septal hypertrophy | Likely pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr11:47353666
- GRCh38:
- Chr11:47332115
| MYBPC3 | N1257K | Primary familial dilated cardiomyopathy, Cardiovascular phenotype, not specified, not provided, Hypertrophic cardiomyopathy | Conflicting interpretations of pathogenicity (Aug 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:47355103
- GRCh38:
- Chr11:47333552
| MYBPC3 | | Heart block, Tachycardia, Asymmetric septal hypertrophy, Premature ventricular contraction, Dyspnea, Hypertrophic cardiomyopathy, Noncompaction cardiomyopathy, Cardiovascular phenotype, Left ventricular noncompaction 10, Hypertrophic cardiomyopathy 4, not providedCardiomyopathy, Hypertrophic cardiomyopathy 4, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy, ...see more | Pathogenic/Likely pathogenic (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:47370092
- GRCh38:
- Chr11:47348541
| MYBPC3 | V219L | Cardiovascular phenotype, Hypertrophic cardiomyopathy 4, Left ventricular noncompaction 10, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 4, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Dec 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:23884860
- GRCh38:
- Chr14:23415651
| LOC126861897, MHRT, MYH7 | R1712Q | Hypertrophic cardiomyopathy | Pathogenic (Dec 9, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:4300
- GRCh38:
- ChrMT:4300
| MT-TI | | Mitochondrial disease | Likely pathogenic (Sep 12, 2022) | reviewed by expert panel FDA Recognized Database |